RDD Online with the support of Aptar Pharma (Valois Pharma and Pfeiffer) will be organizing the Respiratory Drug Delivery (RDD) Europe 2011 from May 3 to 6, 2011 in Berlin.

The worldwide symposium about nasal and pulmonary drug delivery will present latest advancements in human genomics, drug design and delivery technologies, drug development, In Vitro and In Vivo testing methods, and regulatory science through podium sessions and debates; scientific poster sessions; technology exhibition and workshop sessions.

The organizers said that the event would be of use to academic, industrial and regulatory scientists involved in the development, investigation, preparation and delivery of existing and new therapeutic entities by inhalation.

The conference will cover topics like Human Genomics - Therapeutic Implications and Opportunities, Drug Design and Delivery Technologies, Progress in Drug Development, Novel In Vitro and In Vivo Testing Methods and Regulatory Science.

The Scientific Poster Session & Technology Exhibit will run throughout May 4 and May 5. Posters can be reviewed any time the meeting is in session.

There is also a Technology Exhibition in which device and equipment designers plus component and service suppliers present their latest developments in a table top format.

The Workshop sessions will feature practical and interactive demonstrations of innovative technologies, products and services